December 2017: OncoMark attendance at SABCS

December 2017: OncoMark are attending the San Antonio Breast Cancer Symposium (SABCS)

Members of the OncoMark team are attending the annual San Antonio Breast Cancer Symposium (SABCS) from the 5th-9th December 2017. Chief Executive Officer Mr. Des O’Leary, Chief Scientific Officer Prof. William Gallagher and Senior Biostatistician Mr. Stephen Barron are presenting a poster at this event in Hall 1 on Thursday 7th December from 5:00PM-7:00PM entitled “Prognostic value of OncoMasTR: A novel multigene signature based on master transcriptional regulators”. This poster details the development and validation of OncoMasTR, a multigene prognostic test for classifying the risk of distant metastasis in ER-positive, HER2-negative breast cancer patients with up to 3 involved lymph nodes (LN0-3). The OncoMasTR test is being developed and commercialised in accordance with quality management and regulatory requirements.

The OncoMark team welcome and encourage anyone interested to visit the poster and to engage and hear more about OncoMasTR.

Contact details:  Phone 00353-(0)87-7503333 & des.oleary@oncomark.com 

Des O'Leary,
OncoMark CEO